Basic Information
Basic information for C5orf64-212-23aa
Peptide Name C5orf64-212-23aa
Genome Position chr5:61758073-61758141[+]
Species Human
Peptide Sequence MPFITGPRKSLTVTSAILYCSCE
Peptide Length 23
Unique No (C5orf64-209-23aa,C5orf64-214-23aa,C5orf64-216-23aa,C5orf64-220-23aa,C5orf64-227-23aa,C5orf64-228-23aa)
Grand Average of Hydropathicity 0.4783
Relative Molecular Mass 2914.43
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000658416;C5orf64-212
Transcript Length 1847
Coding Ability 0.4164
DNA Sequence Corresponding to Peptide ATGCCCTTTATAACCGGGCCTCGGAAATCCCTCACTGTCACCTCTGCCATACTCTACTGTTCATGTGAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :